Articles by Jill Wechsler - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe
  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jill Wechsler
123456789101112
Next »

Regulatory Convergence Sought for Global Pharma Market

Manufacturers work with international authorities to harmonize drug registration and supply-chain oversight.
May 2, 2013
By: Jill Wechsler

Manufacturers work with international authorities to harmonize drug registration and supply-chain oversight.

Regulatory Roundup

May 2, 2013
By: Jill Wechsler

FDA faces budget crunch; Supreme Court hears key cases

Manufacturers Under Pressure to Manage Painkillers

Opioid abuse generates calls for efforts to curb distribution, develop abuse-resistant formulations.
Apr 2, 2013
By: Jill Wechsler

Opioid abuse generates calls for efforts to curb distribution, develop abuse-resistant formulations.

Regulatory Roundup

Latest news about compound pharmacies, biosimilars, prescription drug purchases, and other regulatory topics.
Apr 2, 2013
By: Jill Wechsler

Latest news about compound pharmacies, biosimilars, prescription drug purchases, and other regulatory topics.

Vaccine Innovation Yields New Products and Processes

Vaccine development is benefiting from manufacturing advances and support for global health.
Mar 2, 2013
By: Jill Wechsler

Vaccine development is benefiting from manufacturing advances and support for global health.

GMP Compliance Becomes Prominent Enforcement Issue

Prosecutors and regulators challenge manufacturing quality failings likely to cause patient harm.
Feb 2, 2013
By: Jill Wechsler

Prosecutors and regulators challenge manufacturing quality failings likely to cause patient harm.

Drug Quality at Center Stage for FDA and Manufacturers

Shortages and compounding disaster spur efforts to overhaul manufacturing oversight and stimulate industry improvements.
Jan 1, 2013
By: Jill Wechsler

Shortages and compounding disaster spur efforts to overhaul manufacturing oversight and stimulate industry improvements.

Health Policy Challenges for Obama Administration

White House and Congress likely to struggle over funding for bio/pharmaceutical regulation.
Dec 2, 2012
By: Jill Wechsler

White House and Congress likely to struggle over funding for bio/pharmaceutical regulation.

Product Analysis Key to Biosimilar Development

Manufacturing and in-depth characterization provide basis for demonstrating product equivalence.
Nov 2, 2012
By: Jill Wechsler

Manufacturing and in-depth characterization provide basis for demonstrating product equivalence.

123456789101112
Next »

ADVERTISEMENT
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
21%
To all process for new products only
13%
To select process for new products only
26%
To select processes for both new and legacy products
21%
Do not use QbD
21%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
FindPharma Custom Search
Featured Jobs

More Jobs
Click here